ESLAW vs TXN
Estrella Immunopharma Inc. (ESLAW) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ. It is led by Haviv Ilan.
ESLAW does not have a complete income-statement cache yet.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
ESLAW currently screens at market cap $0. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the ESLAW and TXN stock pages for the full models.
Not investment advice.